Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (48658)	7/27/2012 9:58:35 AM
From: E_K_S	Read Replies (1) \| Respond to of 78746

Merck & Co. Inc. (NYSE: MRK) - New three year high on pretty good earnings. Merck Profit Tops Estimates As Sales Of Diabetes Drugs Grow goo.gl Merck & Co. (MRK), facing generic competition in August to its top-selling asthma drug Singulair, reported second-quarter profit that beat analyst estimates on higher sales of the diabetes medicines Januvia and Janumet.Earnings excluding one-time items of $1.05 a share beat by 4 cents the average of 18 analyst estimates compiled by Bloomberg. Net income fell 11 percent to $1.79 billion, or 58 cents a share, from $2.02 billion, or 65 cents, a year earlier, the Whitehouse Station, New Jersey-based company said today in a statement. Revenue climbed 1.3 percent to $12.3 billion. There does not seem to be too much concern over the VIOXX litigation as MRK reaches a post crash three year high. MRK has now vaulted past PFE into my top 10 holding position. For now, I will continue to hold my shares but look at peeling off some shares as we are are selling 13% my EKS$ value. My last buy was 6/2009 at $27.30, so I have met my 36 month average holding period. Stock is up 3.07% on today's earnings report. Last $44.62. EKS

To: Sergio H who wrote (48658)	9/25/2012 10:30:27 AM
From: E_K_S	Read Replies (3) \| Respond to of 78746

Abbott Laboratories (ABT) -NYSE - New all time high for the stock last $70.41 Not sure how to value these pharmaceutical companies. I noticed that Pfizer Inc. (PFE) -NYSE is hitting a four year high. I have shares that I have bought and held in the IRA at $26/share (7/2005) and even @ $34.65/share(in 11/2009). I also added a lot more shares below $16.00/share in 6/2010 too. At one point during the pharma growth phase (during the 90's), the market priced a lot of these pharmaceuticals w/ a 25 PE to 30 PE. The forward PE's for these stocks are still quite cheap now selling w/ PE's in the low teens. ABT at PE 13.77 and PFE at 11.09. I continue to hold all my pharma stocks as they pay good dividends. I am not sure if the market is looking to price more growth in these names (perhaps as the baby boomers age) but many are breaking out to multi year highs. ABT at an all time high is a surprise to me too. EKS